Cargando…
Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
BACKGROUND: Studies have demonstrated a potential role for fecal biomarkers such as fecal calprotectin (FC) and fecal lactoferrin (FL) in monitoring inflammatory bowel diseases (IBD) - Crohn’s disease (CD) and ulcerative colitis (UC). However, their correlation to endoscopic scores, disease severity...
Autores principales: | Rubio, Marrieth G, Amo-Mensah, Kofi, Gray, James M, Nguyen, Vu Q, Nakat, Sam, Grider, Douglas, Love, Kim, Boone, James H, Sorrentino, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940564/ https://www.ncbi.nlm.nih.gov/pubmed/31911845 http://dx.doi.org/10.4291/wjgp.v10.i5.54 |
Ejemplares similares
-
Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
por: Kostas, Athanasios, et al.
Publicado: (2017) -
Colon mucosal neoplasia referred for endoscopic mucosal resection: Recurrence of adenomas and prediction of submucosal invasion
por: Rashid, Mamoon Ur, et al.
Publicado: (2020) -
Five years of fecal microbiota transplantation - an update of the Israeli experience
por: Greenberg, Sharon A, et al.
Publicado: (2018) -
Clinical and Health Economic Evaluation of a Novel Device for Fecal Management in Bedridden Patients
por: Sheth, Harsh, et al.
Publicado: (2023) -
Multicenter evaluation of recurrence in endoscopic submucosal dissection and endoscopic mucosal resection in the colon: A Western perspective
por: Wei, Mike T, et al.
Publicado: (2023)